Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Tuberculosis and HIV news

Show

From To
Rapid diagnostic test and shorter, cheaper treatment signal new hope for multidrug-resistant tuberculosis patients

New WHO recommendations aim to speed up detection and improve treatment outcomes for multidrug resistant tuberculosis (MDR-TB) through use of a novel rapid diagnostic test and a shorter, cheaper treatment regimen.

Published
12 May 2016
From
World Health Organization
If we want to end HIV, TB, and malaria, we need to do more to reduce human rights barriers

A recent report from UNAIDS said that by 2020, countries should devote 8% of its HIV resources to reducing human rights barriers to accessing services. Currently, less than 1% of Global Fund grant funds is spent on programs to reduce human rights barriers. We have to do more and we have to do it better, says Ralf Jürgens. In this commentary, Ralf describes an intensive effort that the Global Fund is implementing in 15-20 countries, as well as other initiatives the Fund has planned.

Published
11 May 2016
From
Global Fund Observer
In Côte d’Ivoire, two million TB drugs financed by The Global Fund sold in street markets

In Côte d’Ivoire, the Nouvelle Pharmacie de la Santé Publique (NPSP), the facility responsible for receiving, warehousing and distributing medicines, and the Programme National de Lutte contre la Tuberculose (PNLT), a principal recipient, were responsible for a massive diversion of TB drugs financed by The Global Fund.

Published
19 April 2016
From
Global Fund Observer
STREAM clinical study first to include bedaquiline to test shortened treatment regimens for multidrug-resistant III in Phase III trial

Stage 2 of the trial aims to reduce MDR-TB treatment from 24 months to 6 or 9 months.

Published
18 April 2016
From
International Union Against Tuberculosis and Lung Disease
Isoniazid alone prevents tuberculosis in people with advanced HIV, urine test may lower mortality

Using isoniazid alone to prevent the development of active tuberculosis (TB) in people with advanced HIV disease was equally effective and better tolerated than a common four-drug empirical

Published
25 March 2016
By
Liz Highleyman
Hope's story: "Having TB and HIV is not easy but I am fighting hard"

Sitting in her small flat that she once shared with friends in Zimbabwe's capital Harare, Hope (27), a sex worker chronicles life from her first diagnosis with tuberculosis (TB) and later HIV. A journey, she says, that has never been easy.

Published
24 March 2016
From
AVERT
Battling TB and other outbreaks “staff, stuff, space, and systems ” still lacking

Paul Farmer first saw multidrug-resistant tuberculosis in the early 1990s in Haiti, from where he smuggled a patient’s sputum sample to test for drug resistance in Boston. Months later, Partners in Health co-founder Dr. Jim Kim with other colleagues discovered a cluster of fifty MDR-TB patients in a squatter settlement of 100,000 in Lima, Peru. That’s when they started to talk to the world about the emergence of MDR-TB.

Published
24 March 2016
From
Science Speaks
Just 2% of people with the severest cases of drug-resistant TB currently have access to new, more effective treatments

Two years after two new drugs to treat tuberculosis—the first in over 50 years—were conditionally approved for use, only 2% of the 150,000 people who need them have been able to access them, according to Médecins Sans Frontières (MSF).

Published
24 March 2016
From
Médecins Sans Frontières
WHO calls on countries and partners to "Unite to End Tuberculosis"

While there has been significant progress in the fight against TB, with 43 million lives saved since 2000, the battle is only half-won: over 4 000 people lose their lives each day to this leading infectious disease. Many of the communities that are most burdened by tuberculosis are those that are poor, vulnerable and marginalized.

Published
24 March 2016
From
World Health Organization
With TB now No. 1 global infectious disease killer, USAID justifies cuts to global TB funding

When House Appropriations Committee members in 2014 asked then USAID Administrator Raj Shah how the U.S. could combat tuberculosis globally with 19 percent less money, he said not to worry. The Global Fund to Fight AIDS, TB and Malaria, and the President’s Emergency Plan for AIDS Relief would fill the gap, he said.

Published
21 March 2016
From
Science Speaks

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close